Commercialisation Revenue definition

Commercialisation Revenue means the gross proceeds arising directly from the Commercialisation of IP by the University and actually received in available cash funds by the University in consideration for the grant of a right to Commercialise IP, not including any amounts received which are in consideration for other obligations such as CCR, the conduct of contract or collaborative research or development, or other expenditure obligations, and less all taxes forming part of such amounts.
Commercialisation Revenue means monies received from the commercialisation of intellectual property. It includes but is not limited to: • royalty payments from licensing of IP• royalty payments from sub-licensing of IP• one-off payments from licensing IP, be these in full or part payment for rights to use IP• proceeds from the outright sale of the IP• milestone payments• minimum performance payments• dividends from shares owned by Lincoln in a company to which it grants a license for the use of IP• proceeds of sale of shares owned by Lincoln in a company to which it grants a license for the use of IP Commercialisation Revenue does not include the overhead component of research funds paid pursuant to a research agreement.
Commercialisation Revenue means the gross revenue actually received and retained by the University from the Commercial Exploitation of Intellectual Property, after the payment of any withholding, goods and services or other taxes, bank fees, transaction fees and other charges. Commercialisation Revenue does not include income received from the provision of research, consultancy or other services and does not include any income derived from the delivery of the University’s fee-paying courses, including courses delivered collaboratively with third party educational institutions in Australia or internationally.

Examples of Commercialisation Revenue in a sentence

  • For further details, refer to the Intellectual Property: Commercialisation Revenue – Procedures.

  • Commercialisation Revenue is defined as the gross revenue received by NTUitive from the commercialisation of the IP (including all royalties, fees and other benefits).

  • For the avoidance of doubt income from industry sponsored programmes does not fall under the definition of IP Commercialisation Revenue and the cost of the time commitment by ORI staff to support for the IP commercialisation process shall not be considered a vouchable expense.

  • There are various conflicts of interest that can emerge in relation to Creators receiving Commercialisation Revenue.

  • Similarly, where UOW receives monetary consideration for these services, and applies those monies to purchase shares, these shares are in a different category, and dividends on these shares, and the proceeds of sale of these shares, are not a Commercialisation Revenue.

  • If damages are received by UOW in relation to any infringement, they are received as compensation for Commercialisation Revenues that would otherwise have been expected, and so should properly be included as a Commercialisation Revenue available for distribution.

  • Firms still represent different things to different observers.”).

  • Nominating and Governance Committee Our nominating and governance committee is comprised of Tamar Gottlieb (Chairperson), David Jutkowitz, and Dror Erez, and operates pursuant to a written charter.

  • The decision concerning who is a Creator is to be made by UOW’s authorised delegate(s) considering a recommendation made by the Commercialisation Revenue Committee referred to in the Commercialisation Revenue Policy.

  • This list is not exhaustive, as there may be other types of Commercialisation Revenue which are not included in this list.


More Definitions of Commercialisation Revenue

Commercialisation Revenue means (a) royalty upon sale by licensee; (b) royalty from sub-license fees received from a licensee; (c) lump sum license fee;

Related to Commercialisation Revenue

  • Commercialisation means any and all activities directed to the preparation for sale of, offering for sale of, or sale of a product, including activities related to marketing, promoting, distributing, importing and exporting such product. When used as a verb, “to Commercialise” and “Commercialising” means to engage in Commercialization, and “Commercialised” has a corresponding meaning.

  • Diagnostic Product means In Vitro Diagnostics, In Vivo Diagnostic Agents and any product used for Diagnosis.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Commercializing means to engage in Commercialization and “Commercialized” has a corresponding meaning.

  • Licensed Product means any method, process, composition, product, service, or component part thereof that would, but for the granting of the rights set forth in this Agreement, infringe a Valid Claim contained in the Licensed Patents.

  • Approved Product means any water fitting, plumbing product, material or component which is the subject of an existing WRAS Approval;

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Commercialization Costs means the sum of the following costs and expenses incurred by the Parties or their respective Affiliates, in Commercializing the Shared Products (and related Manufacturing activities) in the Territory, in each case, to the extent incurred in accordance with the Commercialization Plan and Commercialization Budget:

  • Commercialise means to promote, market, distribute and/or sell a Product and “Commercialising” and “Commercialisation” shall be construed accordingly;

  • U.S. Territory means American Samoa, the Commonwealth of the Northern Mariana Islands, Guam, the Commonwealth of Puerto Rico, or the U.S. Virgin Islands.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Licensed service area means the geographic area in which the home service provider is authorized by law or contract to provide commercial mobile radio service to the customer.

  • Net Sales Revenue shall have the meaning as set out in Schedule "A"

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Sublicense Revenues means all revenue, in whatever form but excluding sublicense royalties, earned by the Licensee in consideration of its granting a Third Party a sublicense to make a Licensed Product including, without limitation, receipt of annual milestone attainment, sublicense issuance, maintenance or up-front payments, or technology access fee; and issuance of securities or real, personal or intangible property.

  • Net Sales means [***].

  • Sublicense Revenue means any payments or other consideration that CTI actually receives from a Sublicensee as consideration for the grant of a Sublicense, including, without limitation, milestone payments, license fees, license maintenance fees and equity. Sublicense Revenue excludes (i) purchases of equity or debt of TGTX, (ii) payments made for GTX’s performance of any research, Development, or Commercialization of any Licensed Product, (iii) (b) royalties on Net Sales (or, in the case of a profit sharing deal structure, shares of net profits) which are covered in Section 5.9, and (iv) any payment or reimbursement of any costs or expenses incurred by TGTX for filing, prosecution, maintenance, or defense of any DFCI Patents. In the event such consideration received from a Sublicensee is not cash, Sublicense Revenue shall be calculated by TGTX based on the fair market value of such consideration, at the time of the transaction, assuming an arm’s length transaction made in the odinary course of business.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Licensed Services means all functions performed by the Licensed System.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Generic Product means a product which (a) contains as its active pharmaceutical ingredient a compound that is (or is substantially the same as) the Licensed Compound or the active pharmaceutical contained in a Unity Bcl-2 [***] Product, and (b) has been placed on the market pursuant to a validly granted marketing authorization.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Manufacturing Costs means the costs of Processing that generate Manufacturing Proceeds received by Grantor.

  • Licensed Processes means processes which, in the course of being practiced, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.